E
The Beauty Health Company SKIN
$1.29 -$0.01-0.77%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 5/14/2024Downgrade
The Beauty Health Company (SKIN) was downgraded to E+ from D- on 5/14/2024 due to a noticeable decline in the efficiency index, valuation index and total return index. Total capital declined 7.95% from $811.68M to $747.12M.
D
Sell 12/6/2023Downgrade
The Beauty Health Company (SKIN) was downgraded to D- from D on 12/6/2023 due to a decline in the total return index and volatility index.
D
Sell 11/21/2023Upgraded
The Beauty Health Company (SKIN) was upgraded to D from D- on 11/21/2023 due to an increase in the valuation index.
D
Sell 11/15/2023Upgraded
The Beauty Health Company (SKIN) was upgraded to D- from E+ on 11/15/2023 due to a noticeable increase in the efficiency index and valuation index.
E
Sell 5/18/2023Downgrade
The Beauty Health Company (SKIN) was downgraded to E+ from D+ on 5/18/2023 due to a significant decline in the growth index, efficiency index and solvency index. Net income declined 684.14% from $3.82M to -$22.29M, earnings per share declined from -$0.0218 to -$0.17, and EBIT declined 359.76% from -$3.77M to -$17.31M.
D
Sell 2/15/2023Upgraded
The Beauty Health Company (SKIN) was upgraded to D+ from D on 2/15/2023 due to an increase in the volatility index.
D
Sell 1/30/2023Downgrade
The Beauty Health Company (SKIN) was downgraded to D from D+ on 1/30/2023 due to a noticeable decline in the total return index and volatility index.
D
Sell 11/11/2022Upgraded
The Beauty Health Company (SKIN) was upgraded to D+ from D on 11/11/2022 due to a significant increase in the growth index, efficiency index and volatility index. Earnings per share increased from -$0.0478 to -$0.03.
D
Sell 5/16/2022Upgraded
The Beauty Health Company (SKIN) was upgraded to D from E+ on 5/16/2022 due to an increase in the total return index and volatility index.
E
Sell 5/13/2022Downgrade
The Beauty Health Company (SKIN) was downgraded to E+ from D on 5/13/2022 due to a large decline in the growth index, solvency index and volatility index. Operating cash flow declined 1,273.25% from $3.28M to -$38.47M, EBIT declined 79.71% from -$7.21M to -$12.96M, and earnings per share declined from -$0.1183 to -$0.128.
D
Sell 5/4/2022Upgraded
The Beauty Health Company (SKIN) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and total return index.
E
Sell 5/1/2022Downgrade
The Beauty Health Company (SKIN) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell 4/21/2022Upgraded
The Beauty Health Company (SKIN) was upgraded to D from E+ on 04/21/2022.
E
Sell 4/20/2022Downgrade
The Beauty Health Company (SKIN) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index and total return index.
D
Sell 3/4/2022Downgrade
The Beauty Health Company (SKIN) was downgraded to D from D+ on 3/4/2022 due to a large decline in the volatility index, valuation index and total return index.
D
Sell 1/10/2022Downgrade
The Beauty Health Company (SKIN) was downgraded to D+ from C- on 1/10/2022 due to a noticeable decline in the total return index and volatility index.
C
Hold 11/15/2021Upgraded
The Beauty Health Company (SKIN) was upgraded to C- from D+ on 11/15/2021 due to a major increase in the total return index and valuation index.
D
Sell 8/18/2021None
The Beauty Health Company (SKIN) was downgraded to D+ from U on 08/18/2021.
Weiss Ratings